Skip to content
Home/Companies/MedTech/Resistell
Resistell

Resistell

MedTech·Switzerland·Active·7yr hold
Entry
2019
Hold
7yr
Status
Active

Who owns Resistell?

Resistell is a Swiss MedTech company, currently owned by TRUMPF Venture since 2019.

Hand-verified · updated 2026-07-03

Open JSON · CC-BY
TRUMPF Venture
Investor
TRUMPF Venture
TRUMPF Venture Fund I · 2016 · VC

Key facts

HQSwitzerland
SectorMedTech
StatusActive
Websiteresistell.com

More from TRUMPF Venture Fund I

Other portfolio companies in the same fund.

Ascend Elements
Active
EnergyUS· 2021
Carbice
Active
IndustrialsUS· 2021
Cyr3con
Exited 2022
CybersecurityUS· 2021
to Cyber Security Works
kiutra
kiutra
Active
Deep TechGermany· 2021
L7 Defense
Active
CybersecurityIsrael· 2021
Peers Solutions
Exited 2025
SoftwareGermany· 2020
to edyoucated

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to Bausch + Lomb
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to Omnicell
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany

Questions

Who owns Resistell?

Resistell is currently owned by TRUMPF Venture, through TRUMPF Venture Fund I, since 2019.

When did TRUMPF Venture acquire Resistell?

TRUMPF Venture acquired Resistell in 2019.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue